Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
aminoguanidine c-c chemokine receptor type 2 NA Clinical trial target TTD , DGIDB Diabetic Retinopathy[MeSHID:D003930]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
Disease[MeSHID:D004194]		 2.89 phase 1 unknown
aminoguanidine nitric-oxide synthase inducible NA Clinical trial target TTD , DGIDB Diabetic Retinopathy[MeSHID:D003930]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
Disease[MeSHID:D004194]		 8.68 phase 1 unknown
aminoguanidine nitric-oxide synthase inducible NA Clinical trial target TTD , DGIDB Diabetic Retinopathy[MeSHID:D003930]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Rheumatoid Arthritis[MeSHID:D001172]
Disease[MeSHID:D004194]		 8.68 phase 1 inhibitor
click here to return to the previous page